What Is Driving Growth in the Latin America Aortic Stent Graft Market?

The Latin America Aortic Stent Graft Market is gaining strategic importance as cardiovascular disease prevalence rises and healthcare systems across Brazil, Mexico, and Argentina increasingly adopt minimally invasive vascular procedures.

Aortic stent grafts are endovascular devices used to treat abdominal and thoracic aortic aneurysms by reinforcing weakened arterial walls and preventing rupture. These devices are essential in EVAR (Endovascular Aneurysm Repair) and TEVAR (Thoracic Endovascular Aortic Repair) procedures.

The global aortic stent graft market was valued at USD 3.28 Billion in 2025 and is projected to reach USD 5.76 Billion by 2035, growing at a CAGR of 5.80% (2026–2035). Latin America holds a significant and expanding regional share of this global market, supported by improving healthcare infrastructure and increased surgical capacity.

For investors and healthcare strategists, this region presents a compelling mix of underpenetration, growing demand, and expanding institutional capabilities.

What Is the Latin America Aortic Stent Graft Market and Why Is It Important?

The Latin America Aortic Stent Graft Market includes devices used in treating:

  • Abdominal Aortic Aneurysms (AAA)

  • Thoracic Aortic Aneurysms (TAA)

  • Aortic dissections

These conditions carry high mortality risk if untreated. The shift from open surgery to minimally invasive endovascular procedures has dramatically improved patient outcomes.

Strategic Importance

  • Reduces surgical mortality and recovery time

  • Supports healthcare system efficiency

  • Addresses aging population risks

  • Attracts global device manufacturers

The market is positioned at the intersection of vascular surgery innovation and emerging market healthcare modernization.

What Is the Current Market Size and Forecast Growth?

While precise regional valuation fluctuates by country, Latin America accounts for a meaningful portion of the USD 3.28 Billion global market in 2025.

Market Snapshot

  • Global Market Value (2025): USD 3.28 Billion

  • Global Forecast (2035): USD 5.76 Billion

  • CAGR (2026–2035): 5.80%

  • Latin America: Significant and steadily expanding share

Regional growth is supported by:

  • Rising procedural volumes

  • Increasing hybrid operating room installations

  • Public-private healthcare expansion

The Latin America aortic stent graft market is projected to grow at a rate comparable to or slightly above global averages due to structural demand growth.

What Are the Key Growth Drivers?

Rising Cardiovascular Disease Prevalence

Risk factors such as hypertension, smoking, diabetes, and obesity are increasing across Latin America. These elevate the incidence of aortic aneurysms and related vascular disorders.

Expansion of Minimally Invasive Techniques

EVAR and TEVAR procedures are becoming preferred treatment options due to:

  • Shorter hospital stays

  • Lower complication rates

  • Reduced ICU burden

  • Faster patient recovery

Healthcare Infrastructure Modernization

Countries like Brazil and Mexico are investing heavily in:

  • Advanced cardiovascular centers

  • Imaging technologies (CT angiography)

  • Endovascular surgical training

Growing Private Healthcare Sector

Private hospital networks are expanding rapidly, driving procurement of advanced vascular devices.

Technology Advancements

New-generation stent graft systems offer:

  • Lower profile delivery systems

  • Improved conformability

  • Enhanced sealing technology

  • Better long-term durability

What Challenges Are Restraining the Market?

High Device Costs

Aortic stent graft systems are premium medical devices. Budget constraints in public hospitals limit broader penetration.

Reimbursement Variability

Reimbursement policies differ across Brazil, Mexico, and Argentina, affecting procedural volumes.

Import Dependency

Most advanced devices are imported, leading to:

  • Exposure to currency volatility

  • Tariff pressures

  • Supply chain risks

Skilled Workforce Limitations

Complex endovascular procedures require trained specialists, which remain concentrated in major urban centers.

What Emerging Trends Are Shaping the Industry?

Growth in Thoracic Stent Graft Adoption

While abdominal grafts dominate, thoracic applications are expanding due to improved diagnostics and awareness.

Device Miniaturization

Lower-profile systems enable treatment of patients with complex anatomies.

Custom and Patient-Specific Grafts

Personalized stent graft solutions improve procedural success in complex aneurysm cases.

Increased Surgeon Training Programs

Manufacturers are investing in physician education to accelerate adoption.

How Is the Latin America Aortic Stent Graft Market Segmented?

By Product

Abdominal Aortic Stent Grafts

  • Largest segment

  • Widely used in EVAR procedures

  • Driven by high AAA prevalence

Thoracic Aortic Stent Grafts

  • Fast-growing segment

  • Increasing TEVAR adoption

  • Higher technological complexity

Abdominal grafts currently command the largest market share.

By End User

Hospitals

  • Largest revenue segment

  • Equipped with hybrid operating rooms

  • Manage complex aneurysm cases

Ambulatory Surgical Centers (ASCs)

  • Growing but limited penetration

  • Primarily in private healthcare settings

Others

  • Specialized vascular centers

Hospitals remain the primary procurement channel.

By Country

Brazil

  • Largest market in Latin America

  • Strong cardiovascular centers

  • Public and private system mix

Mexico

  • Rapid private hospital growth

  • Increasing medical tourism

  • Expanding endovascular capacity

Argentina

  • Moderate but stable growth

  • Improving regulatory efficiency

Others

  • Chile, Colombia, and Peru showing gradual expansion

How Does the Regional Regulatory Landscape Impact Growth?

Each country operates independent regulatory frameworks:

  • Brazil: ANVISA

  • Mexico: COFEPRIS

  • Argentina: ANMAT

Approval timelines vary, influencing time-to-market strategies.

Compared to North America and Europe:

  • Longer approval processes in some cases

  • Greater administrative complexity

  • Increasing harmonization efforts

Regulatory navigation is a key competitive differentiator.

What Is the Competitive Landscape?

The Latin America aortic stent graft market features global medtech leaders.

Major Companies Covered

  • Cook Medical, Inc.

  • W.L. Gore & Associates

  • MicroPort Scientific Corporation Inc.

  • Medtronic Plc.

  • Lombard Medical, Inc.

  • Endologix, Inc.

  • Terumo Corporation Inc.

  • Cardinal Health Inc.

  • Becton, Dickinson and Company

  • CryoLife Inc.

Market Positioning

  • Medtronic and W.L. Gore dominate premium segments

  • Cook Medical maintains strong distribution networks

  • Asian players compete on price

Strategic Developments

  • Distribution partnerships

  • Surgeon education programs

  • Introduction of lower-profile devices

  • Expansion into second-tier cities

Competitive intensity is increasing, particularly in Brazil and Mexico.

How Does Latin America Compare Globally?

Compared to mature markets:

  • Lower procedural penetration rates

  • Higher price sensitivity

  • Slower adoption of next-gen graft systems

However:

  • Growth potential is stronger

  • Infrastructure investments are accelerating

  • Underdiagnosis creates latent demand

This combination presents long-term structural opportunity.

What Is the Future Outlook Through 2035?

The Latin America aortic stent graft market is positioned for sustained growth through 2035.

Forecast Themes

  • Continued shift toward minimally invasive vascular repair

  • Rising AAA and TAA diagnosis rates

  • Increased hybrid OR installations

  • Stronger private healthcare investment

Strategic Investment Opportunities

  • Target high-volume tertiary hospitals

  • Focus on Brazil and Mexico

  • Offer competitively priced yet advanced systems

  • Build long-term distribution partnerships

Risk Factors

  • Currency volatility

  • Regulatory delays

  • Public healthcare budget constraints

Overall, the market presents moderate risk with strong structural demand fundamentals.

Discover More Reports

Antimicrobial Hospital Curtains Market

Mastopexy Market

Gas Chromatography Market

Guidewires Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com